Avadel Pharmaceuticals PLC
AVDLDelisted Feb 12, 2026- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001012477
Avadel Pharmaceuticals PLC was delisted on Feb 12, 2026; its insiders filed their last Form 4 on Feb 18, 2026; 208 institutions reported holding it in 13F filings for Q4 2025, worth $1.60B in total; no superinvestor held it.
Q4 2021 vs. Q3 2021
How the institutions holding Avadel Pharmaceuticals PLC changed between Q3 2021 and Q4 2021.
All holders in Q4 2021All holders in Q3 2021
| Measure | Q3 2021 | Of which not filed for Q4 2021 | Q4 2021 | Change |
|---|---|---|---|---|
| Holders | 82 | 1 | 85 | +4 |
| Shares | 32.1M | 301.9K | 35.5M | +3.75M (+11.8%) |
| Value | $314.2M | $2.96M | $287.0M | −$24.3M (−7.8%) |
1 institution that held it in Q3 2021 haven't filed for Q4 2021 yet. Not filing isn't selling, so the changes leave them out.
New holders (17)
Institutions that held Avadel Pharmaceuticals PLC at the end of Q4 2021 but not at the end of Q3 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Wealth Effects LLC | 2,305,017 | $18.6M | 7.73% |
| Acuta Capital Partners, LLC | 580,000 | $4.69M | 1.97% |
| Knott David M Jr | 258,198 | $2.09M | 0.79% |
| Qube Research & Technologies Ltd | 160,206 | $1.29M | 0.01% |
| Jane Street Group, LLC | 80,669 | $652.0K | 0.00% |
| Virtu Financial LLC | 25,427 | $205.0K | 0.02% |
| Trexquant Investment LP | 23,500 | $190.0K | 0.01% |
| Millennium Management LLC | 22,733 | $184.0K | 0.00% |
| LMR Partners LLP | 20,500 | $166.0K | 0.00% |
| Jump Financial, LLC | 16,803 | $136.0K | 0.01% |
| XTX Topco Ltd | 11,788 | $95.0K | 0.05% |
| Creative Planning | 11,351 | $92.0K | 0.00% |
| Cutler Group LP | 3,569 | $28.0K | 0.00% |
| Aquatic Capital Management LLC | 1,400 | $11.0K | 0.02% |
| US Bancorp | 325 | $3.00K | 0.00% |
| Jefferies Group LLC | 44 | $356 | 0.00% |
| Huntington National Bank | 1 | $0 | 0.00% |
Sold out (13)
Institutions that held Avadel Pharmaceuticals PLC at the end of Q3 2021 and filed for Q4 2021 without it.
| Institution | Shares, Q3 2021 | Value, Q3 2021 |
|---|---|---|
| Tri Locum Partners LP | 148,355 | $1.45M |
| Atom Investors LP | 75,786 | $743.0K |
| Mariner, LLC | 38,861 | $381.0K |
| D. E. Shaw & Co., Inc. | 33,041 | $324.0K |
| DekaBank Deutsche Girozentrale | 20,000 | $194.0K |
| HRT Financial LP | 13,728 | $134.0K |
| ProShare Advisors LLC | 12,477 | $122.0K |
| Valeo Financial Advisors, LLC | 10,000 | $98.0K |
| Wolverine Asset Management LLC | 7,791 | $76.0K |
| Quantbot Technologies LP | 5,800 | $56.0K |
| Ibex Wealth Advisors | 1,500 | $15.0K |
| Penserra Capital Management LLC | 1,335 | $13.0K |
| Barclays PLC | 154 | $1.00K |
Not filed for Q4 2021 yet (1)
Institutions that held Avadel Pharmaceuticals PLC at the end of Q3 2021 and haven't filed a 13F for Q4 2021. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q3 2021 | Value, Q3 2021 |
|---|---|---|
| Knott David M | 301,864 | $2.96M |